Abstract:Molecular mimicry between foreign and self-antigens has been implicated as a cause of autoimmune hepatitis in experimental models and cross-reacting antibodies in patients. This review describes the experimental and clinical evidence for molecular mimicry as a cause of autoimmune hepatitis, indicates the limitations and uncertainties of this premise, and encourages investigations that assess diverse environmental antigens as sources of disease-relevant molecular mimics. Pertinent articles were identified in PubMed using multiple search phrases. Several pathogens have linear or conformational epitopes that mimic the self-antigens of autoimmune hepatitis. The occurrence of an acute immune-mediated hepatitis after vaccination for severe acute respiratory syndrome (SARS)-associated coronavirus 2 (SARS-CoV-2) has suggested that vaccine-induced peptides may mimic disease-relevant tissue antigens. The intestinal microbiome is an under-evaluated source of gut-derived antigens that could also engage in molecular mimicry. Chaperone molecules may enhance the pathogenicity of molecular mimics, and they warrant investigation. Molecular mimics of immune dominant epitopes within cytochrome P450 IID6, the autoantigen most closely associated with autoimmune hepatitis, should be sought in diverse environmental antigens and assessed for pathogenicity. Avoidance strategies, dietary adjustments, vaccine improvement, and targeted manipulation of the intestinal microbiota may emerge as therapeutic possibilities. In conclusion, molecular mimicry may be a missing causality of autoimmune hepatitis. Molecular mimics of key immune dominant epitopes of disease-specific antigens must be sought in diverse environmental antigens. The ubiquity of molecular mimicry compels rigorous assessments of peptide mimics for immunogenicity and pathogenicity in experimental models. Molecular mimicry may complement epigenetic modifications as causative mechanisms of autoimmune hepatitis.

Potential clinical implications of molecular mimicry‐induced autoimmunity

Potential Role of Bacterial Infection in Autoimmune Diseases: A New Aspect of Molecular Mimicry

Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis

Evidence for Molecular Mimicry between SARS-CoV-2 and Human Antigens: Implications for Autoimmunity in COVID-19

Molecular mimicry: Can epitope mimicry induce autoimmune disease?

Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction

Exploring the relationship between infectious agents and autoimmune diseases: a review

Molecular Mimicry as a Mechanism of Viral Immune Evasion and Autoimmunity

Molecular mimicry in autoimmune neurological disease after viral infection.

Gut Microbial Antigenic Mimicry in Autoimmunity

Is Molecular Mimicry the Missing Link between Those Two Factors?

Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms

Microbial mimics supersize the pathogenic self-response

The Molecular Basis Of Immune Regulation In Autoimmunity

Mining Autoimmune-Disorder-Linked Molecular-Mimicry Candidates in Clostridioides difficile and Prospects of Mimic-Based Vaccine Design: An In Silico Approach

Human microbiome-derived peptide affects the development of experimental autoimmune encephalomyelitis via molecular mimicry

Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review

Myositis-specific and myositis-associated autoantibodies: their clinical characteristics and potential pathogenic roles

Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease

Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases

Microbial dysbiosis in the gut drives systemic autoimmune diseases